Commentary on Harris & Rhodes (2012): Discouraging syringe re-use by addressing drug injectors' everyday suffering

Addiction

Volumn 107, Issue 6, 2012, Pages 1097-1098

  Koester, Stephen ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Harm reduction; HCV; Qualitative research; Syringe and ancillary paraphernalia sharing; Syringe re use; Venous care.

Indexed keywords

FEMALE; HARM REDUCTION; HEPATITIS C; HUMAN; MALE; NOTE; PATHOLOGY; PERIPHERAL VASCULAR DISEASE; SUBSTANCE ABUSE; VEIN;

FEMALE; HARM REDUCTION; HEPATITIS C; HUMANS; MALE; PERIPHERAL VASCULAR DISEASES; SUBSTANCE ABUSE, INTRAVENOUS; VEINS;

EID: 84860563773     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.03884.x     Document Type: Note

References (13)

1. Paintsil E., He H., Peters C., Lindenbach B. D., Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis 2010; 202: 984-90.
2. Thiede H., Hagan H., Campbell J. V., Strathdee S., Bailey S. L., Hudson S. M. etal. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend 2007; 91S: S39-47.
3. De P., Roy E., Boivin J. F., Cox J., Morissette C. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepatol 2008; 15: 279-92.
4. Harris M., Rhodes T. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs. Addiction 2012; 107: 1090-6.
5. Bourgois P. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Subst Use Misuse 1998; 33: 2323-51.
6. Bourgois P., Schonberg J. Righteous Dopefiend. Berkeley, CA: University of California Press; 2009.
7. Fraser S. 'It's your life!': injecting drug users, individual responsibility and hepatitis C prevention. Health 2004; 8: 199-221.
8. Fraser S., Moore D. Harm reduction and hepatitis C: on the ethics and politics of prevention and treatment. Addict Res Theory 2011; 19: 375-9.
9. Moore D. Governing street-based injecting drug users: a critique of heroin overdose in Australia. Int J Drug Policy 2004; 59: 1547-57.
10. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. Int J Drug Policy 2002; 13: 85-94.
11. Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy 2009; 20: 193-201.
12. Blankenship K. M., Bray S., Merson M. H. Structural interventions in public health. AIDS 2000; 14: S11-21.
13. Turner K. M. E., Hutchinson S., Vickerman P., Hope V., Craine N., Palmateer N. etal. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction 2011; 106: 1978-88.